Prognostic value of plasminogen activator inhibitor‐1 in biomarker exploration using multiplex immunoassay in patients with metastatic renal cell carcinoma treated with axitinib

BACKGROUND AND AIMS: Vascular endothelial growth factor‐directed therapies play a significant role in patients with metastatic renal cell carcinoma (mRCC). Biomarkers for predicting treatment efficacy and resistance are required to develop personalized medicine. We evaluated multiple serum cytokine...

Descripción completa

Detalles Bibliográficos
Autores principales: Honma, Naoko, Inoue, Takamitsu, Tsuchiya, Norihiko, Koizumi, Atsushi, Yamamoto, Ryohei, Nara, Taketoshi, Kanda, Sohei, Huang, Mingguo, Numakura, Kazuyuki, Saito, Mitsuru, Narita, Shintaro, Satoh, Shigeru, Habuchi, Tomonori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559632/
https://www.ncbi.nlm.nih.gov/pubmed/33088925
http://dx.doi.org/10.1002/hsr2.197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559632/
https://www.ncbi.nlm.nih.gov/pubmed/33088925
http://dx.doi.org/10.1002/hsr2.197

Ejemplares similares